mRNA |
AZD8055 |
GDSC1000 |
pan-cancer |
AAC |
0.015 |
0.6 |
mRNA |
Topotecan |
CCLE |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
MS-275 |
GDSC1000 |
pan-cancer |
AAC |
0.024 |
0.6 |
mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.6 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
Doxorubicin |
GDSC1000 |
pan-cancer |
AAC |
0.016 |
0.6 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.6 |
mRNA |
BRD-K02251932 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
Dasatinib |
GDSC1000 |
pan-cancer |
AAC |
-0.022 |
0.7 |
mRNA |
BRD-K99584050 |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.7 |